Leslie Hickman
Nurse Practitioner · Herrin, ILNPI 1184196883
Payments from drug & device makers
Across 240 payments — averaging $14.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$563
- Pfizer$412
- Novo Nordisk$182
- Lilly USA, LLC$127
- Biohaven Pharmaceutical Holding Company Ltd.$123
- plus $468 from 17 others
What the payments were for
- Food & beverage$3,571100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 148 | $1,696 |
| AstraZeneca | 13 | $563 |
| Pfizer | 28 | $412 |
| Novo Nordisk | 9 | $182 |
| Lilly USA, LLC | 6 | $127 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $123 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Phathom Pharmaceuticals, Inc. | 4 | $54 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $53 |
| Impel Pharmaceuticals Inc. | 2 | $42 |
| GSK | 2 | $40 |
| UCB, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $24 |
| Bayer | 1 | $21 |
| Viatris Specialty LLC | 1 | $18 |
| Amgen | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,571 in reported general payments places this provider in the 90th percentile of 4,869 nurse practitioner providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 141 | $119,635 |
| OzempicSemaglutide | 62 | $79,633 |
| EliquisApixaban | 82 | $66,552 |
| TrulicityDulaglutide | 59 | $55,682 |
| FarxigaDapagliflozin Propanediol | 66 | $49,577 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 45 | $35,555 |
| MounjaroTirzepatide | 31 | $31,586 |
| JanuviaSitagliptin Phosphate | 20 | $24,259 |
| RybelsusSemaglutide | 17 | $23,545 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $21,304 |
| LinzessLinaclotide | 21 | $21,136 |
| Breo ElliptaFluticasone/Vilanterol | 28 | $12,572 |
| OxycontinOxycodone Hcl | 14 | $10,492 |
| GlyxambiEmpagliflozin/Linagliptin | 13 | $9,831 |
| DuleraMometasone/Formoterol | 24 | $7,899 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Glyxambi, Combivent Respimat | $15 | $137,015168 claims |
| Novo NordiskOzempic, Rybelsus | $182 | $103,17879 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $127 | $87,26890 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $563 | $85,132111 claims |
| PfizerEliquis | $412 | $66,55282 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $40 | $41,40766 claims |
| AbbVieLinzess | $1,696 | $21,13621 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $14 | $5,31411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,869 nurse practitioner providers in Illinois.
Other nurse practitioner in Herrin
- Erika VuckoChicago$417K
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
- Kristy LukeChicago$77K
- Yvonna OldakerFlossmoor$74K
- Heather PiercePekin$72K
- Dara McKinleyEvanston$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.